Jennifer Rola

Director, Data And Analytics Engineering Lead at Pfizer

Jennifer Rola has extensive experience in the data and analytics field, currently serving as the Director, Data and Analytics Engineering Lead at Pfizer since February 2004. Jennifer's career at Pfizer includes previous roles as a Senior Manager in Business Technology and Manager, along with an earlier position as a Senior Advisor. Prior to Pfizer, Jennifer worked at Inventa as a Principal Consultant II from April 2000 to February 2004 and held the role of Senior Consultant at Millennium Computer System and Sybase Philippines, Inc. throughout the late 1990s.

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Pfizer

614 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.